Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02404103 · ClinicalTrials.gov registry record · NA
Flunisolide HFA in Children With Small Airway Disease
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02404103 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 26 participants.
The verdict
NCT02404103, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled medication to treat asthma) affect the small airways in children with asthma.
Interventions
- DRUG Flunisolide HFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02404103
The ClinicalTrials.gov registry entry for NCT02404103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flunisolide HFA is the first listed.
NCT02404103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02404103 about?
NCT02404103 is a clinical study titled "Flunisolide HFA in Children With Small Airway Disease". The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled medication to treat asthma) affect the small airways in children with asthma.
What is the current status of trial NCT02404103?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2015-03. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02404103?
The interventions under investigation include: Flunisolide HFA (DRUG).
Who is sponsoring clinical trial NCT02404103?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.